Development of tissue-engineered vascular grafts from decellularized parsley stems.
Merve CevikSerkan DikiciPublished in: Soft matter (2023)
Cardiovascular diseases are mostly associated with narrowing or blockage of blood vessels, and it is the most common cause of death worldwide. The use of vascular grafts is a promising approach to bypass or replace the blocked vessels for long-term treatment. Although autologous arteries or veins are the most preferred tissue sources for vascular bypass, the limited presence and poor quality of autologous vessels necessitate seeking alternative biomaterials. Recently, synthetic grafts have gained attention as an alternative to autologous grafts. However, the high failure rate of synthetic grafts has been reported primarily due to thrombosis, atherosclerosis, intimal hyperplasia, or infection. Thrombosis, the main reason for failure upon implantation, is associated with damage or absence of endothelial cell lining in the vascular graft's luminal surface. To overcome this, tissue-engineered vascular grafts (TEVGs) have come into prominence. Alongside the well-established scaffold manufacturing techniques, decellularized plant-based constructs have recently gained significant importance and are an emerging field in tissue engineering and regenerative medicine. Accordingly, in this study, we demonstrated the fabrication of tubular scaffolds from decellularized parsley stems and recellularized them with human endothelial cells to be used as a potential TEVG. Our results suggested that the native plant DNA was successfully removed, and soft tubular biomaterials were successfully manufactured via the chemical decellularization of the parsley stems. The decellularized parsley stems showed suitable mechanical and biological properties to be used as a TEVG material, and they provided a suitable environment for the culture of human endothelial cells to attach and create a pseudo endothelium prior to implantation. This study is the first one to demonstrate the potential of the parsley stems to be used as a potential TEVG biomaterial.
Keyphrases
- tissue engineering
- endothelial cells
- high glucose
- cardiovascular disease
- bone marrow
- vascular endothelial growth factor
- cell therapy
- platelet rich plasma
- pulmonary embolism
- oxidative stress
- extracellular matrix
- working memory
- type diabetes
- human health
- coronary artery disease
- metabolic syndrome
- nitric oxide
- risk assessment
- mesenchymal stem cells
- stem cells
- induced pluripotent stem cells
- climate change
- combination therapy
- circulating tumor
- quality improvement
- cell wall